Concepedia

Anne Robinson

AR

58

Publications

5K

Citations

36

H-Index

1997

Active since

Affiliations

AbbVie (United States)(Current)

University of California San Diego

AbbVie (Germany)

Icahn School of Medicine at Mount Sinai

University of Calgary

Anne Robinson is an author at AbbVie (United States) specializing in medicine, gastroenterology, and immunology.

Top concepts

Publications per year

1997–2022

58

Publications

58

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 883 citations

, , +3

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

Geert D’Haens, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 362 citations

, , +9

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

Marc Ferrante, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 294 citations

, , +7

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

Jean‐Frédéric Colombel, Paul Rutgeerts, William J. Sandborn et al. · Clinical Gastroenterology and Hepatology · 2013 · 245 citations

, , +2

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

Mark T. Osterman, William J. Sandborn, Jean–Frédéric Colombel et al. · Gastroenterology · 2013 · 189 citations

, , +7

Rows per page

1–5 of 58